BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8301116)

  • 1. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
    Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
    J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM; Wallace VA; Timms E; Mak TW
    Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
    Waanders GA; Lees RK; Held W; MacDonald HR
    Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
    Foo-Phillips M; Kozak CA; Principato MA; Abe R
    J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
    Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
    Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the Mls-1a superantigen results in an increased frequency of V beta 14+ T cells.
    Liao NS; Raulet DH
    J Immunol; 1992 Aug; 149(4):1151-5. PubMed ID: 1323609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of an Mls-1a-like superantigen to BALB/c mice by foster-nursing on F1 Mls-1bxa mothers. Sex-influenced onset of clonal deletion.
    Piazzon I; Goldman A; Torello S; Nepomnaschy I; Deroche A; Dran G
    J Immunol; 1994 Aug; 153(4):1553-62. PubMed ID: 7913941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS; Todd GT; Cohen TD; Fairchild RL
    Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period.
    Niimi N; Wajjwalku W; Ando Y; Tomida S; Takeuchi M; Ueda M; Kaneda T; Yoshikai Y
    Eur J Immunol; 1994 Feb; 24(2):488-91. PubMed ID: 8299700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
    J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue distribution of Mtv-7-like exogenous retroviral transcripts and clonal deletion of V beta 6+ T cells in Mls-1b BALB/c mice.
    Desaymard C; Tucek CL; Rocha B; Korman AJ; Papiernik M
    Int Immunol; 1993 Feb; 5(2):217-22. PubMed ID: 8383996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved amino acid residues in the complementarity-determining region 1 of the TCR beta-chain are involved in the recognition of conventional Ag and Mls-1 superantigen.
    Kang J; Chambers CA; Pawling J; Scott C; Hozumi N
    J Immunol; 1994 Jun; 152(11):5305-17. PubMed ID: 8189048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of host radioresistant T cells to the clonal elimination of minor lymphocyte stimulatory-1a reactive T cells in mouse bone marrow chimeras.
    Arase N; Arase H; Good RA; Onoé K
    Cell Immunol; 1994 Jun; 156(1):13-23. PubMed ID: 8200031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.